MDRX - MDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Veradigm Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case | Benzinga
SAN DIEGO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Veradigm Inc. (NASDAQ:MDRX) common stock between February 26, 2021 and June 13, 2023, inclusive (the "Class Period"), have until January 22, 2024 to seek appointment as lead plaintiff of the Veradigm class action lawsuit. Captioned Erwin v. Veradigm Inc., No. 23-cv-16205 (N.D. Ill.), the Veradigm class action lawsuit charges Veradigm as well as certain of its current and former top executive officers with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Veradigm class action lawsuit, please provide your information here:
https://www.rgrdlaw.com/cases-veradigm-inc-class-action-lawsuit-mdrx.html
You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com.
CASE ALLEGATIONS: The Veradigm class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Veradigm had overstated its historical revenues by at least $20 million; (ii) Veradigm had artificially inflated its revenue by recording duplicate transactions, among other things, over a more than two-year period; (iii) Veradigm had artificially inflated its earnings and margins and materially misrepresented demand for Veradigm's products and services; (iv) Veradigm had failed to maintain effective internal controls over its ...